Overview

Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects

Status:
Completed
Trial end date:
2010-08-05
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the pharmacokinetic profile of ropinirole PR after single and multiple doses of the PR-formulation. It will also investigate the safety and tolerability of ropinirole PR after single and multiple doses of PR-formulation.
Phase:
Phase 1
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Ropinirole